256 related articles for article (PubMed ID: 8583211)
21. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in HTLV-I-associated myelopathy.
Umehara F; Okada Y; Fujimoto N; Abe M; Izumo S; Osame M
J Neuropathol Exp Neurol; 1998 Sep; 57(9):839-49. PubMed ID: 9737547
[TBL] [Abstract][Full Text] [Related]
22. Longer dinucleotide repeat polymorphism in matrix metalloproteinase-9 (MMP-9) gene promoter which correlates with higher HTLV-I Tax mediated transcriptional activity influences the risk of HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP).
Kodama D; Saito M; Matsumoto W; Sabouri AH; Izumo S; Arimura K; Usuku K; Bangham CR; Osame M
J Neuroimmunol; 2004 Nov; 156(1-2):188-94. PubMed ID: 15465610
[TBL] [Abstract][Full Text] [Related]
23. Antibody-dependent cell-mediated cytotoxicity (ADCC) in HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP).
Fujihara K; Itoyama Y; Yu F; Kubo C; Goto I
J Neurol Sci; 1996 Oct; 142(1-2):65-9. PubMed ID: 8902722
[TBL] [Abstract][Full Text] [Related]
24. Incidence of human T cell lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis in a long-term prospective cohort study of initially asymptomatic individuals in Brazil.
Romanelli LC; Caramelli P; Martins ML; Gonçalves DU; Proietti FA; Ribas JG; Araújo MG; Carneiro-Proietti AB
AIDS Res Hum Retroviruses; 2013 Sep; 29(9):1199-202. PubMed ID: 23617363
[TBL] [Abstract][Full Text] [Related]
25. Human T cell lymphotropic virus type I (HTLV-I)-specific CD4+ T cells: immunodominance hierarchy and preferential infection with HTLV-I.
Goon PK; Igakura T; Hanon E; Mosley AJ; Barfield A; Barnard AL; Kaftantzi L; Tanaka Y; Taylor GP; Weber JN; Bangham CR
J Immunol; 2004 Feb; 172(3):1735-43. PubMed ID: 14734756
[TBL] [Abstract][Full Text] [Related]
26. Clinical features of HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in northeast Iran.
Shoeibi A; Rafatpanah H; Azarpazhooh A; Mokhber N; Hedayati-Moghaddam MR; Amiri A; Hashemi P; Foroghipour M; Hoseini RF; Bazarbachi A; Azarpazhooh MR
Acta Neurol Belg; 2013 Dec; 113(4):427-33. PubMed ID: 23568138
[TBL] [Abstract][Full Text] [Related]
27. Increased osteopontin expression in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patient cells is associated with IL-17 expression.
Sarkis S; Belrose G; Peloponese JM; Olindo S; Césaire R; Mesnard JM; Gross A
J Clin Virol; 2013 Sep; 58(1):295-8. PubMed ID: 23756056
[TBL] [Abstract][Full Text] [Related]
28. Risk factors and cofactors for human T-cell lymphotropic virus type I (HTLV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in Jamaica.
Krämer A; Maloney EM; Morgan OS; Rodgers-Johnson P; Manns A; Murphy EL; Larsen S; Cranston B; Murphy J; Benichou J
Am J Epidemiol; 1995 Dec; 142(11):1212-20. PubMed ID: 7485068
[TBL] [Abstract][Full Text] [Related]
29. IgG in brain correlates with clinicopathological damage in HTLV-1 associated neurologic disease.
Jernigan M; Morcos Y; Lee SM; Dohan FC; Raine C; Levin MC
Neurology; 2003 Apr; 60(8):1320-7. PubMed ID: 12707436
[TBL] [Abstract][Full Text] [Related]
30. HTLV-I-associated myelopathy/tropical spastic paraparesis: semiautomatic quantification of spinal cord atrophy from 3-dimensional MR images.
Evangelou IE; Massoud R; Jacobson S
J Neuroimaging; 2014; 24(1):74-8. PubMed ID: 22303896
[TBL] [Abstract][Full Text] [Related]
31. Adult T cell leukemia following HTLV-I-associated myelopathy/tropical spastic paraparesis: case reports and implication to the natural course of ATL.
Tamiya S; Matsuoka M; Takemoto S; Shimizu K; Yamaguchi K; Mita S; Uchino M; Ando M; Miyaguni T; Kuniyoshi K
Leukemia; 1995 Oct; 9(10):1768-70. PubMed ID: 7564523
[TBL] [Abstract][Full Text] [Related]
32. HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP): A comparative study to identify factors that influence disease progression.
Matsuura E; Nozuma S; Tashiro Y; Kubota R; Izumo S; Takashima H
J Neurol Sci; 2016 Dec; 371():112-116. PubMed ID: 27871430
[TBL] [Abstract][Full Text] [Related]
33. Histopathological analysis of four autopsy cases of HTLV-I-associated myelopathy/tropical spastic paraparesis: inflammatory changes occur simultaneously in the entire central nervous system.
Aye MM; Matsuoka E; Moritoyo T; Umehara F; Suehara M; Hokezu Y; Yamanaka H; Isashiki Y; Osame M; Izumo S
Acta Neuropathol; 2000 Sep; 100(3):245-52. PubMed ID: 10965793
[TBL] [Abstract][Full Text] [Related]
34. Cerebral and spinal cord changes observed through magnetic resonance imaging in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis: a systematic review.
Bastos Ferreira AP; do Nascimento ADFS; Sampaio Rocha-Filho PA
J Neurovirol; 2022 Feb; 28(1):1-16. PubMed ID: 34981435
[TBL] [Abstract][Full Text] [Related]
35. Antibody titers to HTLV-I-p40tax protein and gag-env hybrid protein in HTLV-I-associated myelopathy/tropical spastic paraparesis: correlation with increased HTLV-I proviral DNA load.
Kira J; Nakamura M; Sawada T; Koyanagi Y; Ohori N; Itoyama Y; Yamamoto N; Sakaki Y; Goto I
J Neurol Sci; 1992 Jan; 107(1):98-104. PubMed ID: 1578240
[TBL] [Abstract][Full Text] [Related]
36. Human T cell lymphotropic virus type 1 (HTLV-1) proviral load of HTLV-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients according to new diagnostic criteria of HAM/TSP.
Grassi MF; Olavarria VN; Kruschewsky Rde A; Mascarenhas RE; Dourado I; Correia LC; de Castro-Costa CM; Galvão-Castro B
J Med Virol; 2011 Jul; 83(7):1269-74. PubMed ID: 21567429
[TBL] [Abstract][Full Text] [Related]
37. Magnetic resonance imaging in HTLV-I associated myelopathy.
Melo A; Moura L; Rios S; Machado M; Costa G
Arq Neuropsiquiatr; 1993 Sep; 51(3):329-32. PubMed ID: 8297235
[TBL] [Abstract][Full Text] [Related]
38. Brain volume measurements in patients with human T-cell lymphotropic virus-1-associated tropical spastic paraparesis.
Griffith C; Bagnato F; Gupta S; Calabrese A; Oh U; Chiu A; Ohayon JM; McAuliffe MJ; Tasciyan TA; Jacobson S
J Neurovirol; 2006 Oct; 12(5):349-55. PubMed ID: 17065127
[TBL] [Abstract][Full Text] [Related]
39. [The current and future approaches to the treatment of HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP)].
Yamano Y; Sato T; Ando H; Araya N; Yagishita N
Nihon Rinsho; 2012 Apr; 70(4):705-13. PubMed ID: 22568157
[TBL] [Abstract][Full Text] [Related]
40. Lack of association between single-nucleotide polymorphisms of pro- and anti-inflammatory cytokines and HTLV-1-associated myelopathy / tropical spastic paraparesis development in patients from Rio de Janeiro, Brazil.
Schor D; Porto LC; Roma EH; Quintana MSB; Fabricio-Silva GM; Bonecini-Almeida MG; Araújo AQ; Andrada-Serpa MJ
BMC Infect Dis; 2018 Nov; 18(1):593. PubMed ID: 30466392
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
